跳至主要内容
临床试验/NCT02542423
NCT02542423Unknown不适用

Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. The ENDOLUNG Study

Centre Hospitalier Universitaire de Besancon0 个研究点目标入组 150 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
入组人数
150
主要终点
Changes of Endocan blood levels after cardiac surgery and its correlation with postoperative pulmonary failure

研究概览

简要总结

According to literature data, Endocan can detect the onset of respiratory failure. The investigators aim to prove its value also for cardiac surgery patients.

详细描述

Endocan is an endothelium derived soluble dermatan sulfate proteoglycan. Literature data shows that alterate levels of its blood concentration correlate with the onset of pulmonary failure in patients with major trauma and septic shock.

In cardiac surgery respiratory failure and infections are threatening complications leading to mortality rates up to 80%. A rapid diagnosis and treatment of this pathology is crucial to improve the clinical outcome.

Unfortunately specific data for the efficacy of Endocan predictive value in cardiac surgery patients are not available.

The investigators aim to determinate if Endocan can be a helpful tool to identify patients developing acute respiratory failure after cardiac surgery and anticipate specific treatment in order to improve survival.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able to give written consent
  • Elective cardiac surgery
  • More than 18 years old

排除标准

  • Less than 18 years old
  • urgency / emergency cardiac surgery
  • pregnancy
  • unable to give written consent
  • oncologic patients
  • concomitant inflammatory or infective pulmonary disease

结局指标

主要结局

Changes of Endocan blood levels after cardiac surgery and its correlation with postoperative pulmonary failure

时间窗: from day -1 of the intervention to day 3, one blood sample per day

The investigators will enroll 150 patients undergoing elective cardiac surgery. Every participant will be prelevated of several blood samples following this time frame : day -1 from intervention, day 0 ( six hours after intervention), day 1 , day 2 , day 3. All patients will be observed to detect all infections, especially pulmonary ones, up to hospital discharge. Endocan blood levels of patients developing pulmonary failure and patients without postoperative respiratory insufficiency will be compared.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Andrea PERROTTI

Medical Doctor

Centre Hospitalier Universitaire de Besancon

相似试验

Endocan Predictive Value in Postcardiac Surgery... | 临床试验